Skip to main content

Web Exclusives

FDA Approvals
Sarclisa Newest Treatment Approved by the FDA for Patients with Multiple Myeloma
Read More
In the Literature, Oncology
Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes
Read More
FDA Approvals, In the News
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Read More
FDA Approvals, In the News
Mixed Findings in Annual Cancer Statistics Report
Read More
FDA Approvals, In the News
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
Perspectives
Paying Tribute to Geno J. Merli, MD, MACP
David B. Nash, MD, MBA
Read More
FDA Approvals, In the News
Recap of FDA Drug Approvals in 2019
Read More
Pancreatic Cancer, Oncology
A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer
Read More
In the News, Pediatric Cancer, Oncology
FDA Will Require Early Assessment of New Targeted Agents That May Be Used in Pediatric Cancers
Read More
FDA Approvals, In the News
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
Read More
Page 17 of 37
Results 161 - 170 of 362